Back to Journals » ClinicoEconomics and Outcomes Research » Volume 13
Original Research
Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
5,414 | Dovepress* | 4,927+ | 622 | 5,549 | |
PubMed Central* | 487 | 146 | 633 | ||
Totals | 5,414 | 768 | 6,182 | ||
*Since 22 April 2021 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
4 | 0 | 0 | 0 | 2 | 2 |
View citations on PubMed Central and Google Scholar